In ovarian cancer cell lines, knock down of Rac1 expression decreased fibronectin production [13], reversed EMT as measured by increased E-cadherin and decreased vimentin expression [46,47], inhibited tumor cell migration and invasion [47] and reduced tumor growth in a xenograft model [47]. This evidence concerns the gene RAC1 and ovarian carcinoma.